Credit Suisse’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $763K | Sell |
48,438
-479
| -1% | -$7.55K | ﹤0.01% | 2423 |
|
|
2023
Q4 | $741K | Sell |
48,917
-1,391
| -3% | -$21.1K | ﹤0.01% | 2526 |
|
|
2023
Q3 | $1.01M | Sell |
50,308
-9,505
| -16% | -$191K | ﹤0.01% | 2291 |
|
|
2023
Q2 | $1.69M | Buy |
59,813
+22,444
| +60% | +$633K | ﹤0.01% | 2020 |
|
|
2023
Q1 | $643K | Buy |
37,369
+12
| +0% | +$206 | ﹤0.01% | 2585 |
|
|
2022
Q4 | $752K | Sell |
37,357
-375
| -1% | -$7.55K | ﹤0.01% | 2523 |
|
|
2022
Q3 | $818K | Buy |
37,732
+2,339
| +7% | +$50.7K | ﹤0.01% | 2448 |
|
|
2022
Q2 | $995K | Buy |
35,393
+15,764
| +80% | +$443K | ﹤0.01% | 2373 |
|
|
2022
Q1 | $905K | Buy |
19,629
+2,278
| +13% | +$105K | ﹤0.01% | 2586 |
|
|
2021
Q4 | $1.46M | Buy |
17,351
+4,953
| +40% | +$416K | ﹤0.01% | 2343 |
|
|
2021
Q3 | $827K | Buy |
12,398
+163
| +1% | +$10.9K | ﹤0.01% | 2695 |
|
|
2021
Q2 | $652K | Sell |
12,235
-730
| -6% | -$38.9K | ﹤0.01% | 2872 |
|
|
2021
Q1 | $563K | Sell |
12,965
-18,409
| -59% | -$799K | ﹤0.01% | 2884 |
|
|
2020
Q4 | $1.63M | Buy |
+31,374
| New | +$1.63M | ﹤0.01% | 2257 |
|